Avanos Medical, Inc. (AVNS) |
| 24.805 0.045 (0.18%) 05-29 15:59 |
| Open: | 24.78 |
| High: | 24.815 |
| Low: | 24.75 |
| Volume: | 587,262 |
| Market Cap: | 1,161(M) |
| PE Ratio: | -15.5 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 29.09 |
| Resistance 1: | 24.91 |
| Pivot price: | 24.74 |
| Support 1: | 24.69 |
| Support 2: | 24.55 |
| 52w High: | 24.91 |
| 52w Low: | 9.303 |
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
| EPS | -1.600 |
| Book Value | 16.760 |
| PEG Ratio | 0.00 |
| Gross Profit | 7.653 |
| Profit Margin (%) | -10.39 |
| Operating Margin (%) | 5.38 |
| Return on Assets (ttm) | 0.9 |
| Return on Equity (ttm) | -9.2 |
Fri, 29 May 2026
Avanos Medical (NYSE: AVNS) to be acquired for $25.00 per share by AIP‑backed buyer - Stock Titan
Tue, 26 May 2026
A Look At Avanos Medical (AVNS) Valuation After Its Recent Share Price Surge - simplywall.st
Tue, 12 May 2026
Avanos Medical (AVNS) director awarded 12,003 cash-settled RSUs - Stock Titan
Mon, 11 May 2026
Deciphering Avanos Medical (AVNS) International Revenue Trends - Yahoo Finance
Tue, 05 May 2026
Avanos Medical, Inc. Announces First Quarter 2026 Results - PR Newswire
Tue, 05 May 2026
Avanos Medical (AVNS) Lags Q1 Earnings Estimates - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |